Diabetes DTx startup Better Therapeutics heads to public markets in SPAC deal

The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.    
Source: mobihealthnews - Category: Information Technology Tags: Mergers and acquisitions, Finance, Investing, Health and Wellness, Disease management, Digital Health, Business, Care, Technology Source Type: news